IGF2-Lr3 | |
| Quantity: | 1mg |
| Purity: | >97% by HPLC |
| Appearance: | Sterile filtered white lyophilized (freeze-dried) powder |
| AA Sequence: | |
| Reconstitution: | We recommend that this vial be briefly centrifuged prior to opening to settle the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at < -20°C. Further dilutions should be made in appropriate buffered solutions. |
| Storage: | This lyophilized preparation is stable at 2-8°C, but should be kept at -20°C for long term storage, preferably with dessicant. Upon reconstitution, the preparation is stable when stored at 2-8°C. For maximum stability, apportion the reconstituted preparation into working aliquots and store at -20°C. Avoid repeat freeze/thaw cycles. |
Manufactured in Canada by cGMP & ISO:9001 Certified Facility
HPLC and Mass Spectro available upon request.
